Literature DB >> 8558840

FK506 nephrotoxicity: morphologic and physiologic characterization of a rat model.

I E Stillman1, T F Andoh, E A Burdmann, W M Bennett, S Rosen.   

Abstract

BACKGROUND: FK506 is a useful agent in the prevention of allograft rejection but has recently been shown to be nephrotoxic. EXPERIMENTAL
DESIGN: Sprague-Dawley rats (n = 40) were divided into four groups: control (C); low-salt (LS); FK506, 3 mg/kg daily by gavage (FK); and FK506-low-salt (FK-LS). After 6 weeks, the animals underwent physiologic studies and were sacrificed with perfusion fixation of the kidneys. Semiquantitative analysis of morphologic injury was performed as well as grading of juxtaglomerular apparatus (JGA) granularity (1-micron plastic sections). Computer-assisted morphometry was used to measure medullary thick ascending limb (mTAL) size within the inner stripe.
RESULTS: Serum creatinine and plasma renin activity were significantly elevated only in the FK-LS group, but both FK groups had significantly increased fractional excretion of Mg. Tubular atrophy and fibrosis involving medullary rays and inner stripe (areas of low oxygen availability) was minimally present in FK, but prominent in FK-LS (P < 0.001). Injury correlated with decreased function (P < 0.001). Variance of mTAL size, an expression of co-existent tubular atrophy and hypertrophy was significantly greater in FK-LS and correlated with decreased renal function and urine osmolality (P < 0.001). JGA granularity was increased by FK506 (P < 0.006) with the highest values in FK-LS (P < 0.001), and strongly correlated with injury (P < 0.001). JGA granularity did not correlate with circulating renin activity levels, suggesting local activation of a renin-angiotensin system.
CONCLUSIONS: FK506 compromises renal parenchymal zones which are known to have limited oxygen availability (medullary ray and inner stripe), a pattern that has been observed with other nephrotoxins. The injury is potentiated by salt depletion and may be mediated by the renin-angiotensin system. Furthermore, these findings illustrate the close correlation between the medullary injury that was observed and the impaired function that was documented.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8558840

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  12 in total

1.  Tacrolimus (FK506)-Associated Renal Pathology.

Authors:  Parmjeet S Randhawa; Thomas E Starzl; Anthony Jake Demetris
Journal:  Adv Anat Pathol       Date:  1997-07       Impact factor: 3.875

Review 2.  Immunosuppressant-induced nephropathy: pathophysiology, incidence and management.

Authors:  A J Olyaei; A M de Mattos; W M Bennett
Journal:  Drug Saf       Date:  1999-12       Impact factor: 5.606

3.  Genomic-derived markers for early detection of calcineurin inhibitor immunosuppressant-mediated nephrotoxicity.

Authors:  Yuxia Cui; Qihong Huang; James Todd Auman; Brian Knight; Xidong Jin; Kerry T Blanchard; Jeff Chou; Supriya Jayadev; Richard S Paules
Journal:  Toxicol Sci       Date:  2011-08-24       Impact factor: 4.849

4.  Chronic cyclosporin A nephrotoxicity, P-glycoprotein overexpression, and relationships with intrarenal angiotensin II deposits.

Authors:  R G del Moral; M Andujar; C Ramírez; M Gómez-Morales; M Masseroli; M Aguilar; A Olmo; F Arrebola; M Guillén; M J García-Chicano; F F Nogales; F O'Valle
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

5.  Coenzyme Q10 alleviates tacrolimus-induced mitochondrial dysfunction in kidney.

Authors:  Ji Hyun Yu; Sun Woo Lim; Kang Luo; Sheng Cui; Yi Quan; Yoo Jin Shin; Kyung Eun Lee; Hong Lim Kim; Eun Jeong Ko; Byung Ha Chung; Ju Hwan Kim; Sang J Chung; Chul Woo Yang
Journal:  FASEB J       Date:  2019-08-20       Impact factor: 5.191

6.  Benefit of theophylline administration in tacrolimus-induced nephrotoxicity in rats.

Authors:  Gwenn E McLaughlin; Michelle Schober; Maria Perez; Phillip Ruiz; Bernard W Steele; Carolyn Abitbol
Journal:  Pediatr Nephrol       Date:  2003-06-26       Impact factor: 3.714

7.  Protective effect of mycophenolate mofetil against nephrotoxicity and hepatotoxicity induced by tacrolimus in Wistar rats.

Authors:  Hanen Ferjani; Amira El Arem; Aicha Bouraoui; Abedellatif Achour; Salwa Abid; Hassen Bacha; Imen Boussema-Ayed
Journal:  J Physiol Biochem       Date:  2016-01-09       Impact factor: 4.158

8.  Inhibition of dipeptidyl peptidase IV protects tacrolimus-induced kidney injury.

Authors:  Sun W Lim; Long Jin; Shang G Piao; Byung H Chung; Chul W Yang
Journal:  Lab Invest       Date:  2015-08-03       Impact factor: 5.662

9.  Proximal Tubular Injury in Medullary Rays Is an Early Sign of Acute Tacrolimus Nephrotoxicity.

Authors:  Diane Cosner; Xu Zeng; Ping L Zhang
Journal:  J Transplant       Date:  2015-06-24

10.  Dipeptidyl peptidase IV inhibitor MK-0626 attenuates pancreatic islet injury in tacrolimus-induced diabetic rats.

Authors:  Long Jin; Sun Woo Lim; Kyoung Chan Doh; Shang Guo Piao; Jian Jin; Seong Beom Heo; Byung Ha Chung; Chul Woo Yang
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.